It’s like that story of the guy who told his friend a UFO landed next to him and three aliens got out and talked with him—completely unbelievable to most people. That’s how it feels telling the world about Leronlimab: we say we have a drug that can potentially cure or control multiple cancers, and they look at us like we’re crazy. But the data is real. This is not fiction but science.

We need a buyout—ASAP.